Improvement in lipid levels in antiretroviral-experienced HIV-infected patients who are failing therapy and are switched to an atazanavir-containing regimen

被引:0
|
作者
Lichtenstein, K
Clumeck, N
Bellos, N
Rodriguez, C
Estrada, V
Gialelis, K
Sankoh, S
Ledesma, E
机构
[1] Univ Colorado Hlth Sci, Denver, CO USA
[2] Ctr Hosp Univ St Pierre, Brussels, Belgium
[3] SW Infect Dis Associates, Dallas, TX USA
[4] Hosp Clin San Carlos, Buenos Aires, DF, Argentina
[5] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Co, Hopewell, NJ USA
[7] Bristol Myers Squibb Co, Waterloo, Belgium
[8] Hosp Argerich, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
119
引用
收藏
页码:L79 / L80
页数:2
相关论文
共 50 条
  • [1] Body composition changes in treatment-experienced HIV-infected patients initiating an atazanavir-containing antiretroviral regimen
    Tsekes, G.
    Chini, M.
    Lioni, A.
    Tsogas, N.
    Mangafas, N.
    Boboli, M.
    Lazanas, M. C.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L23 - L23
  • [2] Rescue therapy with once-daily atazanavir-based regimens for antiretroviral-experienced HIV-infected patients
    Dronda, F
    Antela, A
    Pérez-Elías, MJ
    Casado, JL
    Moreno, A
    Moreno, S
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (02) : 258 - 259
  • [3] Lipid improvement with atazanavir therapy in an antiretroviral-experienced population: experience in the atazanavir Early Access Program
    Corales, RB
    Coffey, C
    Gordon, F
    Fine, SM
    Christie, ML
    Mang, KM
    Valenti, WM
    Maa, JF
    Thal, G
    Tudor, J
    [J]. ANTIVIRAL THERAPY, 2003, 8 (04) : L46 - L47
  • [4] Treatment of heavily antiretroviral-experienced HIV-infected patients
    Van Lunzen, Jan
    [J]. AIDS REVIEWS, 2007, 9 (04) : 246 - 253
  • [5] Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir
    Sension, Michael
    de Andrade Neto, Jose Luiz
    Grinsztejn, Beatriz
    Molina, Jean Michel
    Zavala, Isidro
    Gonzalez-Garcia, Juan
    Donnelly, Alice
    Phiri, Phillip
    Ledesma, Emilio
    McGrath, Donnie
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (02) : 153 - 162
  • [6] Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
    Lu, Ching-Lan
    Lin, Yu-Hui
    Wong, Wing-Wai
    Lin, Hsi-Hsin
    Ho, Mao-Wang
    Wang, Ning-Chi
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Hung, Chien-Ching
    Chen, Mao-Yuan
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (04) : 258 - 264
  • [7] Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study
    Dolling, David I.
    Dunn, David T.
    Sutherland, Katherine A.
    Pillay, Deenan
    Mbisa, Jean L.
    Parry, Chris M.
    Post, Frank A.
    Sabin, Caroline A.
    Cane, Patricia A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2339 - 2343
  • [8] Tipranavir:: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients
    de Mendoza, Carmen
    Morello, Judit
    Garcia-Gasco, Pilar
    Rodriguez-Novoa, Sonia
    Soriano, Vincent
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (06) : 839 - 850
  • [9] Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients
    De Mendoza, Carmen
    Garrido, Carolina
    Corral, Angelica
    Ramirez-Olivencia, German
    Jimenez-Nacher, Inmaculada
    Zahonero, Natalia
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (07) : 879 - 885
  • [10] Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients
    Bocket, L.
    Peytavin, G.
    Alidjinou, E. K.
    Ajana, F.
    Choisy, P.
    Le, M.
    Charpentier, C.
    Descamps, D.
    Yazdanpanah, Yazdan
    Katlama, C.
    Simon, A.
    Calvez, V.
    Marcelin, A. -G.
    Soulie, C.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2651 - 2653